Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection

Anne M. Wertheimer, Camette Miner, David Lewinsohn, Anna W. Sasaki, Ezra Kaufman, Hugo R. Rosen

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

Spontaneous resolution of hepatitis C virus (HCV) infection is a relatively infrequent event, and these individuals provide a unique opportunity to characterize correlates of protective immunity as an important first step in the development of vaccine candidates. The aim of this study was to directly and comprehensively enumerate HCV-nonstructural protein 3 (NS3) specific CD4+ and CD8+ T cells ex vivo from HLA diverse individuals who had been successful in spontaneously resolving HCV infection. We measured interferon gamma (IFN-γ) production with an ELISPOT assay using magnetic bead-separated CD4+ or CD8+ T cells in response to autologous DCs that had been pulsed with 15mer per peptides overlapping by 11 amino acids and spanning all of the NS3 protein (150 total peptides). All subjects with spontaneously recovered HCV infection demonstrated vigorous and multispecific CD4+ T-cell responses to NS3 peptides, and 6 of 10 subjects demonstrated CD8+ T-cell responses. More importantly, we identified novel, previously unpredicted antigenic regions, which in most cases elicited high frequencies within a given individual. In conclusion, subjects who have spontaneously eradicated HCV infection up to 35 years earlier demonstrate persistent CD4+ and CD8+ T-cell responses specific to NS3. By providing a comprehensive screening of all potential T-cell epitopes contained in the NS3 region, our strategy defines the breadth of the T-cell response and identifies novel, unpredicted specificities.

Original languageEnglish (US)
Pages (from-to)577-589
Number of pages13
JournalHepatology
Volume37
Issue number3
DOIs
StatePublished - Mar 1 2003

Fingerprint

Virus Diseases
Hepacivirus
T-Lymphocytes
Proteins
Peptides
Enzyme-Linked Immunospot Assay
T-Lymphocyte Epitopes
Interferon-gamma
Immunity
Vaccines
Amino Acids

ASJC Scopus subject areas

  • Hepatology

Cite this

Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. / Wertheimer, Anne M.; Miner, Camette; Lewinsohn, David; Sasaki, Anna W.; Kaufman, Ezra; Rosen, Hugo R.

In: Hepatology, Vol. 37, No. 3, 01.03.2003, p. 577-589.

Research output: Contribution to journalArticle

Wertheimer, Anne M. ; Miner, Camette ; Lewinsohn, David ; Sasaki, Anna W. ; Kaufman, Ezra ; Rosen, Hugo R. / Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection. In: Hepatology. 2003 ; Vol. 37, No. 3. pp. 577-589.
@article{adf6487185364288b4e54d09fa8ae727,
title = "Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection",
abstract = "Spontaneous resolution of hepatitis C virus (HCV) infection is a relatively infrequent event, and these individuals provide a unique opportunity to characterize correlates of protective immunity as an important first step in the development of vaccine candidates. The aim of this study was to directly and comprehensively enumerate HCV-nonstructural protein 3 (NS3) specific CD4+ and CD8+ T cells ex vivo from HLA diverse individuals who had been successful in spontaneously resolving HCV infection. We measured interferon gamma (IFN-γ) production with an ELISPOT assay using magnetic bead-separated CD4+ or CD8+ T cells in response to autologous DCs that had been pulsed with 15mer per peptides overlapping by 11 amino acids and spanning all of the NS3 protein (150 total peptides). All subjects with spontaneously recovered HCV infection demonstrated vigorous and multispecific CD4+ T-cell responses to NS3 peptides, and 6 of 10 subjects demonstrated CD8+ T-cell responses. More importantly, we identified novel, previously unpredicted antigenic regions, which in most cases elicited high frequencies within a given individual. In conclusion, subjects who have spontaneously eradicated HCV infection up to 35 years earlier demonstrate persistent CD4+ and CD8+ T-cell responses specific to NS3. By providing a comprehensive screening of all potential T-cell epitopes contained in the NS3 region, our strategy defines the breadth of the T-cell response and identifies novel, unpredicted specificities.",
author = "Wertheimer, {Anne M.} and Camette Miner and David Lewinsohn and Sasaki, {Anna W.} and Ezra Kaufman and Rosen, {Hugo R.}",
year = "2003",
month = "3",
day = "1",
doi = "10.1053/jhep.2003.50115",
language = "English (US)",
volume = "37",
pages = "577--589",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Novel CD4+ and CD8+ T-cell determinants within the NS3 protein in subjects with spontaneously resolved HCV infection

AU - Wertheimer, Anne M.

AU - Miner, Camette

AU - Lewinsohn, David

AU - Sasaki, Anna W.

AU - Kaufman, Ezra

AU - Rosen, Hugo R.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Spontaneous resolution of hepatitis C virus (HCV) infection is a relatively infrequent event, and these individuals provide a unique opportunity to characterize correlates of protective immunity as an important first step in the development of vaccine candidates. The aim of this study was to directly and comprehensively enumerate HCV-nonstructural protein 3 (NS3) specific CD4+ and CD8+ T cells ex vivo from HLA diverse individuals who had been successful in spontaneously resolving HCV infection. We measured interferon gamma (IFN-γ) production with an ELISPOT assay using magnetic bead-separated CD4+ or CD8+ T cells in response to autologous DCs that had been pulsed with 15mer per peptides overlapping by 11 amino acids and spanning all of the NS3 protein (150 total peptides). All subjects with spontaneously recovered HCV infection demonstrated vigorous and multispecific CD4+ T-cell responses to NS3 peptides, and 6 of 10 subjects demonstrated CD8+ T-cell responses. More importantly, we identified novel, previously unpredicted antigenic regions, which in most cases elicited high frequencies within a given individual. In conclusion, subjects who have spontaneously eradicated HCV infection up to 35 years earlier demonstrate persistent CD4+ and CD8+ T-cell responses specific to NS3. By providing a comprehensive screening of all potential T-cell epitopes contained in the NS3 region, our strategy defines the breadth of the T-cell response and identifies novel, unpredicted specificities.

AB - Spontaneous resolution of hepatitis C virus (HCV) infection is a relatively infrequent event, and these individuals provide a unique opportunity to characterize correlates of protective immunity as an important first step in the development of vaccine candidates. The aim of this study was to directly and comprehensively enumerate HCV-nonstructural protein 3 (NS3) specific CD4+ and CD8+ T cells ex vivo from HLA diverse individuals who had been successful in spontaneously resolving HCV infection. We measured interferon gamma (IFN-γ) production with an ELISPOT assay using magnetic bead-separated CD4+ or CD8+ T cells in response to autologous DCs that had been pulsed with 15mer per peptides overlapping by 11 amino acids and spanning all of the NS3 protein (150 total peptides). All subjects with spontaneously recovered HCV infection demonstrated vigorous and multispecific CD4+ T-cell responses to NS3 peptides, and 6 of 10 subjects demonstrated CD8+ T-cell responses. More importantly, we identified novel, previously unpredicted antigenic regions, which in most cases elicited high frequencies within a given individual. In conclusion, subjects who have spontaneously eradicated HCV infection up to 35 years earlier demonstrate persistent CD4+ and CD8+ T-cell responses specific to NS3. By providing a comprehensive screening of all potential T-cell epitopes contained in the NS3 region, our strategy defines the breadth of the T-cell response and identifies novel, unpredicted specificities.

UR - http://www.scopus.com/inward/record.url?scp=0037369712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037369712&partnerID=8YFLogxK

U2 - 10.1053/jhep.2003.50115

DO - 10.1053/jhep.2003.50115

M3 - Article

C2 - 12601356

AN - SCOPUS:0037369712

VL - 37

SP - 577

EP - 589

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -